Flamel Technologies SA (NASDAQ:FLML)

15.65
Delayed Data
As of Feb 27
 +0.35 / +2.29%
Today’s Change
9.30
Today|||52-Week Range
19.50
-8.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$604.3M

Company Description

Flamel Technologies SA engages in the development, manufacture, and marketing of pharmaceutical products. It operates under the following trademarks: Flamel Technologies, Bloxiverz, Micropump, LiquiTime, Trigger Lock, Medusa, DeliVax, and Vazculep. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France.

Contact Information

Flamel Technologies SA
33, avenue du Dr. Georges Lévy
Vénissieux Rhone-alpes 69200
P:(347) 278-3434
Investor Relations:

Employees

Shareholders

Other institutional51.00%
Mutual fund holders19.32%
Individual stakeholders--

Top Executives

Michael Shannon AndersonChief Executive Officer & Director
Rafael JordaChief Operating Officer & Executive Vice President
Siân CrouzetChief Financial Officer
Christian KalitaChief Pharmacist, Director-Quality & Regulatory
Phillandas T. ThompsonSenior Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account